"10.1371_journal.pone.0133203","plos one","2015-07-15T00:00:00Z","Guillaume B√©raud; Sabine Kazmercziak; Philippe Beutels; Daniel Levy-Bruhl; Xavier Lenne; Nathalie Mielcarek; Yazdan Yazdanpanah; Pierre-Yves Bo√´lle; Niel Hens; Benoit Dervaux","M√©decine Interne et Maladies Infectieuses, Centre Hospitalier de Poitiers, Poitiers, France; EA2694, Universit√© Droit et Sant√© Lille 2, Lille, France; Interuniversity Institute for Biostatistics and statistical Bioinformatics, Hasselt University, Hasselt, Belgium; CRESGE, Universit√© Catholique de Lille, Lille, France; Centre for Health Economics Research & Modeling Infectious Diseases (CHERMID), Vaccine & Infectious Disease Institute, Universiteit Antwerpen, Antwerpen, Belgium; D√©partement des maladies infectieuses, InVS, Saint-Maurice, France; D√©partement d‚Äôinformation m√©dicale, Universit√© de Lille Nord de France, Centre Hospitalier Universitaire de Lille, Lille, France; Center for Infection and Immunity of Lille, Institut Pasteur de Lille, Lille, France; INSERM U1019, Lille, France; CNRS UMR8204, Lille, France; Universit√© Lille-Nord de France, Lille, France; Service des Maladies Infectieuses et tropicales, H√¥pital Bichat Claude Bernard, Paris, France; UMR-S 707, INSERM, Paris, France; DRCI, Centre Hospitalier Universitaire de Lille, Lille, France","Conceived and designed the experiments: BD NH PB DLB XL YY SK NM PYB. Performed the experiments: SK BD. Analyzed the data: GB NH PB BD. Wrote the paper: GB SK PB DLB XL NM YY PYB NH BD.","GlaxoSmithKline provided an unconditional grant to Universit√© Catholique de Lille to which SK is affiliated to. The survey for this study was carried out by IPSOS. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2015","07","Guillaume B√©raud","GB√",10,TRUE,9,2,4,10,TRUE,TRUE,FALSE,0,NA,FALSE
